Raleigh Startup Unveils Approach to Prevent Alzheimer's Utilizing Artificial Intelligence

A startup in Raleigh, N.C., has introduced a novel approach for dealing with Alzheimer's driven by artificial intelligence (AI), as part of a project launched by the Women's Alzheimer's Movement Prevention Center at Cleveland Clinic, reports WRAL TechWire . uMETHOD's patented ExtND METHOD can reportedly prevent Alzheimer's by enabling doctors to tailor treatment plans to individuals. The technique applies proprietary AI to interpret data from blood and urine tests, including demographics, medical history, and lifestyle. The AI then matches data against current Alzheimer's research to produce individual care plans. "Researchers . . . have long recognized that Alzheimer's disease . . . will need personalized combinations of treatments to improve patient outcomes," said uMETHOD Health CEO Vik Chandra. He added that federal regulatory approval is unnecessary. "We are a decision support software and do not need FDA approval," said Chandra. "Our treatment recommendations are provided to healthcare professionals who use them in the care of their patients."